发明授权
- 专利标题： Sustained release drug formulations containing a carrier peptide
- 专利标题（中）： 含有载体肽的缓释药物制剂
-
申请号： US10506263申请日： 2003-03-04
-
公开(公告)号： US07943575B2公开(公告)日： 2011-05-17
- 发明人: Jacques-Pierre Moreau , Roland Cherif-Cheikh
- 申请人： Jacques-Pierre Moreau , Roland Cherif-Cheikh
- 申请人地址： FR Boulogne Billancourt
- 专利权人： Ipsen Pharma S.A.S.
- 当前专利权人： Ipsen Pharma S.A.S.
- 当前专利权人地址： FR Boulogne Billancourt
- 代理机构： Hunton & Williams LLP
- 国际申请： PCT/US03/06676 WO 20030304
- 国际公布： WO03/075887 WO 20030918
- 主分类号： A61K38/22
- IPC分类号： A61K38/22
摘要：
The invention features a method of administering one or more therapeutic agents to a patient and delivering said agent or agents continuously over an extended period of time, said method comprising: obtaining a pharmaceutical composition including a peptide carrier, one or more therapeutic agents, and up to 30 percent, by weight, of a pharmaceutically acceptable, soluble, monomeric carrier; and parenterally administering said pharmaceutical composition to a subject by injection, wherein said composition automatically forms a gel after interaction with the patient's bodily fluids and releases said peptide carrier and said agent or agents continuously within the patient over an extended period.
公开/授权文献
信息查询
IPC分类:
